A Curated Platform of Equity & Options Market Intelligence
Select Page

GILD

Search by
TICKER SYMBOL

Gilead Sciences, Inc.

Sector:
Industry:

66.76

0.6

(0.907%)

Volume:

10,657,002

52 week range:

65.9 - 86.09

Market Cap:

83.121B

Company Description:

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.